Biomarkers of Erectile Dysfunction

To address erectile dysfunction (ED), it’s important to evaluate multiple factors, including endothelial function, free testosterone levels, insulin resistance, anxiety/mood, and overall energy.

Certain blood chemistry markers and biomarkers, particularly those related to glucose regulation, cardiovascular health, and inflammation, can offer valuable insights into the underlying causes and potential risks

Cardiovascular and Inflammation Factors

• Cholesterol and Triglycerides: Elevated levels are associated with ED, reflecting the shared pathophysiology between ED and cardiovascular disease. 
• hs-troponin T and hs-troponin I: Elevated levels of these cardiac biomarkers have been associated with ED and increased mortality risk. 
• C-Reactive Protein (CRP): Elevated CRP levels, especially hsCRP, are associated with ED, particularly in men with diabetes. 
• Neutrophil-to-lymphocyte Ratio (NLR): An increased NLR is an independent risk factor for ED. 
• Homocysteine: Elevated levels are associated with endothelial dysfunction and atherosclerosis, risk factors in ED.
• Platelet-lymphocyte ratio (PLR): An elevated PLR reflects systemic inflammation, which is associated with diabetes and cardiovascular disease.

Endothelial Function

• hs-CRP (C-reactive protein): Elevated levels indicate systemic inflammation and may be associated with endothelial dysfunction.
• Fibrinogen Activity: An important marker of inflammation and blood clotting, which can affect endothelial health.
• OxLDL: Oxidized LDL is a contributor to endothelial dysfunction and can indicate vascular damage.
• ADMA: Asymmetric dimethylarginine is an inhibitor of nitric oxide production and is directly linked to endothelial dysfunction.

Hormonal Parameters:

• Testosterone: Low testosterone levels can contribute to ED and decreased libido.
• Sex Hormone-Binding Globulin (SHBG): SHBG binds to testosterone, affecting the amount of free, bioavailable testosterone.
• Prolactin and Thyroid Hormone: Evaluated in a subset of patients to rule out other hormonal imbalances. 
• Testosterone Free (Male): A key marker for evaluating testosterone levels in men, directly related to erectile function.
• Testosterone Total (Male): Total testosterone levels can be useful, but free testosterone is a more accurate reflection of bioavailable testosterone.
• Insulin-like Growth Factor-1 (IGF-1): Serum IGF-1 levels may be a specific predictor of ED. 
• Adiponectin: Lower levels of adiponectin are often found in men with insulin resistance and ED.

Insulin Resistance

• Glucose – Fasting: This is a primary biomarker for assessing insulin resistance and diabetes, a significant risk factor for erectile dysfunction (ED). 
• Insulin - Fasting: This is a key marker for assessing insulin resistance, which is often a contributing factor to erectile dysfunction.
• Hemoglobin A1C (%): Used to evaluate long-term blood sugar control and assess for diabetes or prediabetes.
• HOMA2-IR, HOMA2-%B, and HOMA2-%S: These indices help assess beta-cell function and insulin sensitivity, which are crucial for evaluating insulin resistance.
• Triglyceride-Glucose Index (TyG): This index serves as a marker for insulin resistance and metabolic syndrome, conditions that are associated with erectile dysfunction.
• C-peptide: Elevated levels indicate increased insulin secretion, often linked with ED in the context of metabolic disorders.

Anxiety/Mood

• Cortisol (Total AM/PM): Cortisol, a key stress hormone, can become elevated in chronic stress, potentially affecting mood and erectile function.
• DHEA-S (Male): DHEA-S, a precursor to both testosterone and estrogen, plays a role in stress resilience and mood regulation.

Energy Optimization

• Coenzyme Q10 (CoQ10): Essential for mitochondrial function; deficiencies can lead to low energy and sexual dysfunction.
• B Vitamin panel: Including B12, Folate, and B6 (important for mitochondrial function and energy production).
• Magnesium: Magnesium is essential for energy production, glucose regulation, and muscle function, and deficiencies can lead to fatigue.
• Vitamin D (25-OH): Low vitamin D levels can contribute to fatigue and mood disturbances, impacting overall energy.

Biomarkers available in ODX to evaluate ED

Basic panel

• CBC with differential to calculate neutrophil-to-lymphocyte ratio and platelet-lymphocyte ratio
• Cortisol AM/PM
• DHEA-S
• Fasting glucose and insulin with calculation of HOMA2-IR, %B, and %S
• Hemoglobin A1C
• Hs CRP
• Lipid panel
• Magnesium
• Sex hormone binding globulin
• Testosterone (free, total, bioavailable)
• Triglyceride-Glucose Index (calculated from triglycerides and glucose)

Additional biomarkers to enhance clinical evaluation:

• ADMA
• B vitamins
• CoQ10
• Fibrinogen activity
• Homocysteine
• IGF-1
• Oxidized LDL
• Prolactin
• Troponins
• TSH and thyroid hormones
• Vitamin D

Additional biomarkers outside of ODX that can help evaluate ED factors:

• Monocyte-to-lymphocyte ratio (MLR): MLR has been shown to have a high predictive power for both ED and all-cause mortality. 
• Systemic Immune-Inflammation Index (SII): Higher SII is associated with an increased risk of ED. 
• Endothelin-1 (ET-1): Elevated ET-1 levels in plasma are observed in patients with erectile dysfunction (ED), particularly those with organic ED disorders. 
• miRNA-21: Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients. 
• Vascular Cell Adhesion Molecule-1 (VCAM-1): A marker of endothelial dysfunction. 
• Endothelial Progenitor Cells (EPCs) and Microparticles: These are markers of endothelial function. 

Optimal Takeaways

• While many of these biomarkers are of research interest, some have clinical utility in evaluating and managing ED. 
• For example, measuring testosterone levels is a first-line test in men with ED to rule out hypogonadism. 
• Evaluating cardiovascular risk factors and inflammatory markers can help identify and manage underlying conditions that contribute to ED. 
• Further research is needed to determine the full clinical utility of these biomarkers in ED management. 
• It is also important to monitor and control blood pressure as high blood pressure can damage blood vessels, leading to ED. 

References

Bendall, Jennifer K et al. “Tetrahydrobiopterin in cardiovascular health and disease.” Antioxidants & redox signaling vol. 20,18 (2014): 3040-77. 

Corona, Giovanni, et al. "Low Testosterone and Erectile Dysfunction." Journal of Sexual Medicine, vol. 9, no. 7, 2012, pp. 1724-1736.

Cheung, B. M., et al. "Psychological Stress, Cortisol, and Erectile Dysfunction." Psychosomatic Medicine, vol. 72, no. 2, 2010, pp. 120-127.

Davies, Kelvin P, and Arnold Melman. “Markers of erectile dysfunction.” Indian journal of urology : IJU : journal of the Urological Society of India vol. 24,3 (2008): 320-8. doi:10.4103/0970-1591.42612

DePalma, Ralph G et al. “Optimal serum ferritin level range: iron status measure and inflammatory biomarker.” Metallomics : integrated biometal science vol. 13,6 (2021): mfab030. doi:10.1093/mtomcs/mfab030 

Fest, Jesse et al. “Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study.” Scientific reports vol. 8,1 10566. 12 Jul. 2018, doi:10.1038/s41598-018-28646-w

Kalyani, Rita R., et al. "Erectile Dysfunction and Metabolic Syndrome: Mechanisms and Implications." Current Diabetes Reviews, vol. 14, no. 5, 2018, pp. 459-466.

Kotsis, Vassilis, et al. "Endothelial Dysfunction in Erectile Dysfunction: Mechanisms and Implications." Current Diabetes Reviews, vol. 7, no. 1, 2011, pp. 39-47.

Leslie, Stephen W. and Thushanth Sooriyamoorthy. “Erectile Dysfunction.” StatPearls, StatPearls Publishing, 9 January 2024.

Liao, Zhangcheng et al. “The Relationship Between Hematologic Parameters and Erectile Dysfunction.” Sexual medicine vol. 9,4 (2021): 100401. doi:10.1016/j.esxm.2021.100401

Liu, Chunhui et al. “Association between inflammatory indexes and erectile dysfunction in U.S. adults: National Health and Nutrition Examination Survey 2001-2004.” Sexual medicine vol. 11,4 qfad045. 9 Aug. 2023, doi:10.1093/sexmed/qfad045

Mottl, Andrew, et al. "Insulin Resistance and Erectile Dysfunction: A Critical Review." Endocrinology & Metabolism Clinics of North America, vol. 42, no. 3, 2013, pp. 541-555.

Raharinavalona, Sitraka A et al. “What is the best biological parameter to predict erectile dysfunction in men aged >55 years with type 2 diabetes?.” Journal of diabetes investigation vol. 11,1 (2020): 170-173. doi:10.1111/jdi.13089

Ricci, Giancarlo, et al. "Energy and Erectile Function: The Role of Coenzyme Q10." International Journal of Impotence Research, vol. 25, no. 3, 2013, pp. 127-133.

Selvin, Elizabeth et al. “Elevated Cardiac Biomarkers, Erectile Dysfunction, and Mortality in U.S. Men: NHANES 2001 to 2004.” JACC. Advances vol. 2,4 (2023): 100380. doi:10.1016/j.jacadv.2023.100380

Steppan, Jan, et al. "Endothelial Dysfunction in Erectile Dysfunction: Pathophysiology and Implications for Treatment." European Journal of Clinical Investigation, vol. 41, no. 3, 2011, pp. 287-296.

Tran, C. D., et al. "Free Testosterone and Its Relationship to Erectile Dysfunction." The Journal of Urology, vol. 183, no. 3, 2010, pp. 1293-1298.

Vlachopoulos, Charalambos et al. “Biomarkers, erectile dysfunction, and cardiovascular risk prediction: the latest of an evolving concept.” Asian journal of andrology vol. 17,1 (2015): 17-20. doi:10.4103/1008-682X.143250

Wylie, Kevin, and Jonathan D. L. Hall. "Psychological Factors in Erectile Dysfunction: The Role of Anxiety and Depression." Journal of Sexual Medicine, vol. 9, no. 6, 2012, pp. 1563-1573.

Yafi, Faysal A et al. “Erectile dysfunction.” Nature reviews. Disease primers vol. 2 16003. 4 Feb. 2016, doi:10.1038/nrdp.2016.3

Zaman, Jameela, et al. "Thyroid Dysfunction and Erectile Dysfunction: A Comprehensive Review." Endocrine Practice, vol. 19, no. 5, 2013, pp. 933-942.

Zhang, Yi et al. “The relationship between complete blood cell count-derived inflammatory biomarkers and erectile dysfunction in the United States.” Scientific reports vol. 14,1 32014. 30 Dec. 2024, doi:10.1038/s41598-024-83733-5

Zhong, Lian et al. “Higher systemic immune-inflammation index is associated with increased risk of erectile dysfunction: Result from NHANES 2001-2004.” Medicine vol. 102,45 (2023): e35724. doi:10.1097/MD.0000000000035724